Bibliografie (Referenties)
(1) Williams DR, Da Silva R et al.
Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-‐ parkinsonism. Brain 2005; 128: 1247-‐58. (2) Zampieri C, Di Fabio RP.
Progressive supranuclear palsy: disease profile and rehabilitation strategies.
Phys Ther 2006; 86: 870-‐880.
(3) Burn D, Warren N.
Toward future therapies in Progressive supranuclear palsy.
Mov Disor 2005; 20: S92-‐S98.
(4) Poppe I, De Vil L, Cras P.
Zorgbehoefte bij progressieve supranucleaire paralyse.
Tijdschrift voor Geneeskunde 2011; 67 – in druk
(5) Sosner J, Wall GC, Sznajder J.
Progressive supranuclear palsy: clinical presentation and rehabilitation of two patients.
Arch Phys Med Rehabil 1993; 74: 537-‐539.
(6) Steffen T, Boeve B, Mollinger-‐Riemann L.
Long-‐term locomotor training for gait and balance in a patient with mixed progressive supranuclear palsy and corticobasal degeneration.
Phys Ther 2007; 87: 1078-‐1087.
(7) Zampieri C, Di Fabio RP.
Balance and eye movement training to improve gait in people with progressive supranuclear palsy: quasi-‐randomized clinical trial.
Phys Ther 2008; 88: 1460-‐1473.
(8) Sjöström AC, Holmberg B, Strang P.
Parkinson-‐plus patients-‐an unknown group with severe symptoms.
J of Neurosci Nurs 2002; 34: 314-‐319.
(9) Strauss A, Corbin J.
Basic considerations. In:
Basics of qualitative research.
2nd ed. California: Sage Publications,
1998; 1-‐54.
(10) Glaser G, Strauss A.
The discovery of Grounded Theory. In:
The discovery of Grounded Theory: Strategies for qualitative research.
4th ed. New Jersey: Aldine,
2009; 1-‐18.
(11) Schrag A, Ben-‐Shlomo Y, Quinn NP.
Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-‐sectional study. Lancet 1999; 354: 1771-‐1775. (12) Gomm R.
Key Concepts in Social Research Methods.
1st ed. Hampshire: Palgrave Macmillan,
2009; 367 -‐ 368
(13) Grudens-‐Schuck N, Lundy Allen B et al.
Focus Group Fundamentals.
Iowa State University Extension
2004
(14) Larson K, Grudens-‐Schuck N, et al.
Can You Call It a Focus Group?.
Iowa State University Extension
2004
(15) Morgan D, Krueger R.
Focus Group Kit. (volumes 1-‐6)
London: Sage Publications,
1997
(16) Baarda D.B, de Goede P.M, Teunissen J.
Observeren, hoe doe ik dat? In:
Basisboek Kwalitatief Onderzoek.
2nd ed. Groningen: Stenfert Kroese,
2005; 258-‐299.
(17) Baarda D.B, de Goede P.M, Teunissen J.
Interviewen, hoe doe ik dat? In:
Basisboek Kwalitatief Onderzoek.
2nd ed. Groningen: Stenfert Kroese,
2005; 224-‐256.
(18) Baarda D.B, de Goede P.M, Teunissen J.
Hoe analyseer ik mijn kwalitatieve gegevens? In:
Basisboek Kwalitatief Onderzoek.
2nd ed. Groningen: Stenfert Kroese
2005; 314-‐334.
(19) Boeije H.
Doing Qualitative Analysis. In:
Analysis in Qualitative Research
1st ed. London: Sage Publications Ltd,
2010; 93-‐121.
(20) Suteerawattananon M, MacNeill B, Protas EJ.
Supported treadmill training for gait and balance in a patient with progressive supranuclear palsy.
Phys Ther 2002; 82: 485-‐495.
(21) RIZIV-‐INAMI. (2010). Lijst van zware aandoeningen – E lijst. Geraadpleegd op
4 oktober 2010 via http://www.riziv.fgov.be/care/nl/kines/general-‐ information/nomenclature/article7/ listeE.htm (22) Becky R, Lowrey.
Progressive supranuclear palsy: an overview & importance of rehabilitation.
J Behavioral Optometry 2000; 11: 127-‐132.
(23) Weisz RR, Richer SP, Jordan M, Tucker EG.
Case report: prismatic redirection of vision for progressive supranuclear palsy.
J Am Optom Assoc 1991; 62: 537-‐539.
(24) Vzw Gouverneur Kinsbergen. (2011). Modem. Geraadpleegd op 4 april 2011
via http://modem.kinsbergenvzw.be/ (25) Ward C.
Characteristics and symptom management of progressive supranuclear palsy: a multidisciplinary approach.
J Neurosci Nurs 2006; 38:242-‐247. (26) Hyson HC, Johnson AM, Jog MS.
Sublingual atropine for sialorrhea secondary to parkinsonism: a pilot study.
Mov Disord 2002; 17: 1318-‐20.
(27) Racette BA, Good L, Sagitto S, Perlmutter JS.
Botulinum toxin B reduces sialorrhea in parkinsonism.
Mov Disord 2003; 18: 1059-‐1061.
(28) Postma AG, Heesters M, van Laar T.
Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism.
Mov Disord 2007; 22: 2430-‐2435.
(29) Vlaamse zorgverzekering
Vlaams Agentschap Zorg en Gezondheid. (2010). De Vlaamse zorgverzekering. Geraadpleegd op 1 oktober 2009 via http://www.zorg-‐en-‐gezondheid.be/
zorgverzekering.aspx (30) Vlaams Agentschap voor Personen met een Handicap. (2007). Geraadpleegd
op 1 oktober 2009 via http://www.vaph.be/vlafo/view/nl/ (31) Vlaamse Parkinson Liga (z.d). Geraadpleegd op 1 oktober 2009 via
http://www.parkinsonliga.be/
(32) Society for Progressive Supranuclear Paralyse. (2009). Geraadpleegd op 1
oktober 2009 via http://www.psp.org. (33) The PSP Association. (2008). Geraadpleegd op 1 oktober 2009 via
http://www.pspeur.org/ (34) Msa-‐ams.be vzw (2008-‐2011). Geraadpleegd op 12 oktober 2010 via
http://www.parkinson-‐plus.org
